2.00
11.11%
+0.20
Finanzdaten der Context Therapeutics Inc-Aktie (CNTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
22.63%
0.2247
|
0.2904 | 0.2933 | 0.3555 | 0.3279 |
Operating Expenses |
10.62%
7.1579
|
6.4709 | 5.5856 | 7.0221 | 4.2102 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
10.62%
7.1579
|
6.4709 | 5.5856 | 7.0221 | 4.2102 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
12.18%
-6.9332
|
-6.1805 | -5.2924 | -6.6665 | -3.8823 |
Net Interest Income/Expense |
22.63%
0.2247
|
0.2904 | 0.2933 | 0.3555 | 0.3279 |
Nonoperating Income/Loss |
499.51%
-0.0614
|
0.0154 | -0.0122 | 0.00269 | -0.0023 |
Income/Loss From Continuing Operations Before Tax |
22.63%
0.2247
|
0.2904 | -5.0113 | -6.3083 | 0.3279 |
Income/Loss From Continuing Operations After Tax |
15.24%
-6.7699
|
-5.8747 | -5.0113 | -6.3083 | -3.5568 |
Net Income/Loss
|
15.24%
-6.7699
|
-5.8747 | -5.0113 | -6.3083 | -3.5568 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
100.00%
-
|
15.97 | 15.97 | 15.97 | - |
Diluted Average Shares |
100.00%
-
|
15.97 | 15.97 | 15.97 | - |
Basic Earnings Per Share |
13.51%
-0.42
|
-0.37 | -0.31 | -0.40 | -0.22 |
Diluted Earnings Per Share |
13.51%
-0.42
|
-0.37 | -0.31 | -0.40 | -0.22 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):